Analyst Ratings for Chemomab Therapeutics (CMMB)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 5/13/2024 | Maxim Group » Updated 2/20/2025 |
Michael Okunewitch | New Coverage | Buy (N/A) |
7.00 (4.00) |
0.84 (2.75) |
227.38% | Details |
| 5/6/2024 | Oppenheimer » Updated 8/27/2025 |
Jeff Jones | Upgrade | Outperform (Perform) |
25.00 (10.00) |
0.74 (2.75) |
271.62% | Details |
 |
||||||||
|
||||||||
|
||||||||
